Revolutionary Procedure Takes Control of High Eye Pressure and Prevents Irreversible Vision Loss

More than 3 million people in the United States are affected by Glaucoma, an eye disease caused by increased pressure in the eye and it can also cause damage to the optic nerve which carries visual information from the eyes to the brain. If left untreated, glaucoma can cause permanent damage to the eye, which means vision loss cannot be reversed. Prescription eye drops are the most common treatment for glaucoma, but they can be difficult to administer correctly and can cause uncomfortable or irritating side effects for most patients. High rates of non-compliance and non-adherence to prescription medications contribute to disease progression.

"With iDose TR, we confront the standard practice of relying on topical drops, which may cause unpleasant side effects and be challenging to properly administer multiple times a day," said Dr. Christine Funke. "By delivering an effective therapy directly inside of the eye, iDose TR is an alternative to prescription eye drops and a hands-free way to keep eye pressure under control. The high rate of efficacy of iDose gives me the confidence to perform a standalone glaucoma procedure knowing many patients will gain freedom from their topical therapy. iDose gives physicians and patients a solution for the huge problem of non-compliance; as a result, glaucoma clinic has become a place with happy grateful patients", says Dr. Funke.

Developed by Glaukos, iDose TR reduces high or elevated pressure within the eye by automatically releasing the same type of medication used for decades in the most commonly prescribed eye drops. During a clinical study, 8 out of 10 patients did not need prescription eye drops 12 months after administration of iDose TR. iDose TR may be particularly beneficial for patients who have difficulty adhering to a daily medication regimen or whose condition is uncontrolled on topical glaucoma medications. "Barnet Dulaney Perkins is dedicated to providing our patients with the most advanced treatment options available, iDose gives physicians and patients a solution for the huge problem of non-compliance when using drops; as a result, my glaucoma clinic has become a place with happy grateful patients", says Dr. Funke. "iDose TR represents a significant development in how we can proactively address glaucoma care, and we are proud to be among the first practices to make this therapy available."

Advantages of iDose® TR

• Sustained Medication Release: Delivers consistent levels of medication, reducing IOP fluctuations.
• Improved Compliance: Eliminates the need for daily eye drops, addressing adherence challenges.
• Minimally Invasive Procedure: Implanted during a quick outpatient procedure with minimal recovery time.
• Reduced Side Effects: By delivering medication directly into the eye, it minimizes common side effects associated with topical treatments.
• Long-Term Efficacy: Clinical studies have shown that approximately 80% of patients remained free from additional glaucoma medications for at least 12 months post-implantation.

To learn more about innovative glaucoma treatments available at Barnet Dulaney Perkins Eye Center, visit https://www.goodeyes.com/ or call 602-955-1000 to schedule a comprehensive medical eye exam.

About Barnet Dulaney Perkins Eye Center
Barnet Dulaney Perkins Eye Center, an affiliate of American Vision Partners, has been providing state-of-the-art medical and surgical eye care in Arizona for over 35 years. With a commitment to advanced technology and compassionate care, its team of experienced eye specialists helps patients protect, improve and preserve their sight for life.

SOURCE Barnet Dulaney Perkins Eye Center